Novālent Ltd.

📍 Greensboro, United States👥 13 employees💰 Last funded Jan 2022
Chemical Manufacturing🌐 novalent.com
Website LinkedIn
Novalent® is a leading US biotechnology engineering firm which has pioneered the development of long-lasting technology to protect against germs. Novalent® technology is based on a patented, non-toxic monomolecular layer that continuously kills germs for up to 90 days on surfaces and up to 24 hours on human skin after application. Used by leading US firms including PepsiCo, Pilgrims and HanesBrands, Novalent is private equity backed and is headquartered in Greensboro, North Carolina, with sales offices in five locations around the world.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Novālent Ltd.?
Novālent Ltd. has 2 investors on record on gritt.io.
When did Novālent Ltd. last raise funding?
The most recent investment in Novālent Ltd. recorded on gritt.io was in January 2022.
What industry is Novālent Ltd. in?
Novālent Ltd. operates in Chemical Manufacturing. Find similar Chemical Manufacturing investors on gritt.io.
Where is Novālent Ltd. based?
Novālent Ltd. is headquartered in Greensboro, United States.